EMD-4591

Single-particle
3.3 Å
EMD-4591 Deposition: 01/02/2019
Map released: 17/04/2019
Last modified: 06/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-4591

Archive Files (Depositor)

Primary 3D volume (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-6qm8 summary report (pdf.gz) Map-6qm8 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

Leishmania tarentolae proteasome 20S subunit apo structure

EMD-4591

Single-particle
3.3 Å
EMD-4591 Deposition: 01/02/2019
Map released: 17/04/2019
Last modified: 06/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Leishmania tarentolae
Sample: Proteasome 20S subunit
Fitted models: 6qm8

Deposition Authors: Goswami P, Rowland P
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition.
PUBMED: 30962368
DOI: doi:10.1073/pnas.1820175116
ISSN: 1091-6490
ASTM: PNASA6